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Oligodendrocyte Progenitor Cells (OPCs) first appear at mid embryogenic stages during development of the 
mammalian CNS and a mitotically active population of them remains present even into late adulthood. During the life-time of the 
organism they initially proliferate and migrate in order to populate the whole nervous tissue, then they massively generate 
oligodendrocytes and finally they switch to a less mitotically active phase generating new oligodendrocytes at a slow rate in the 
adult brain; importantly, they can regenerate acutely or chronically destroyed myelin. All the above depend on the capacity of 
OPCs to regulate their cell cycle within different contexts. In this review we describe the development of OPCs, their differential 
mitotic behavior in various conditions (embryo, disease, ageing), we discuss what is known about the mechanisms that control 




 The generation of Oligodendrocytes (OLs) from Oligodendrocyte Progenitor Cells (OPCs) constitutes a crucial step 
during the development of the Central Nervous System (CNS). Every OL extends multiple processes, each one of which wraps 
around a neuronal axon in order to form a membranous multilayered sheath called myelin, thus ensuring the integrity and trophic 
support of the axon, as well as the successful propagation of neuronal activity via saltatory conduction. OPCs are derived from 
different areas of the ventral and dorsal embryonic neuro-epithelium (1), they are massively generated after mid-gestation in the 
mouse embryo and subsequently populate the whole CNS through extensive proliferation and migration. Myelination of axons 
largely occurs in the early postnatal stages and with its completion the majority of perinatal OPCs have exited the cell cycle in 
order to terminally differentiate into mature OLs. However, a subpopulation of OPCs survives for the life span of the organism 
(both in humans and rodents) as adult OPCs scattered throughout the grey and white matter where it represents approximately 5% 
of all cells (2) (Figure 1). Recent experimental work in the mouse has revealed that adult OPCs probably sustain myelin 
homeostasis by continuing to proliferate and to generate new OLs in the adult brain (3-5); albeit exhibiting a gradually slower 
cell cycle and with a fraction of them eventually entering senescence (6). Importantly, in response to demyelination (as in the 
context of multiple sclerosis) adult OPCs can drive a robust endogenous repair process called remyelination during which 
denuded axons are ensheathed by newly-formed OLs. This is achieved through the proliferation and differentiation of local OPCs 
and the recruitment of more distant progenitors that rapidly migrate to the area. Failure of remyelination can lead to impaired 
integrity and function of the axon and subsequent neuropathologies (reviewed in Franklin &ffrench-Constant) (7). In addition to 
their role in repair, adult OPCs –for example in the grey mater- might also contribute in the homeostasis of neurons through a 
range of functions, such as metabolic support (8, 9).  
 
 As in other types of stem and progenitor cells, cell cycle regulation is crucial for OPCs to achieve their developmental 
role, as well as to maintain their population in the adult and aging CNS so as to contribute to homeostasis and to respond 
efficiently in cases of degeneration. In this review we will discuss the cell cycle characteristics of OPCs throughout development, 
ageing and disease and we will summarize the key controlling mechanisms. Most of the information we will refer to is derived 
from experimental work in mice and rats; however, reference to the human CNS will be made whenever possible. It should also 
be noted that here we pool together published information that has been generated by experiments in which cells expressing a 
subset from a range of OPC-specific markers (such as A2B5, NG2, Nkx2.2., Olig2, O4 and Sox10) are investigated each time, 












During embryogenesis of the mouse the first OPCs emerge at around embryonic day 12 (E12) at the ventral 
neuroepithelium of the spinal cord (pMN domain), generated from the same progenitors that had previously generated motor 
neurons. Few days later, at E15 a second wave of OPCs emerges from the dorsal neuroepithelium of the spinal cord (11-13), 
while a third less well-characterized wave of OPC generation occurs around birth (14). In the forebrain, the bulk of OPCs emerge 
after the peak of neurogenesis, again in three waves: the first is driven by neuroepithelial cells of a transient proliferative zone 
called medial ganglionic eminence at E12, the second from progenitors of the lateral ganglionic eminence at around E15 and the 
third perinatally from progenitors of dorsal location (1). In the human brain OPCs are already detectable at 5 gestational weeks 
and it is suggested that a subpopulation is generated from dorsal proliferative zones (15). Interestingly, the switch in lineage 
commitment of forebrain neural progenitors from neurogenesis to oligodendrogenesis is accompanied by a significant change in 
their mode of proliferation, with an increase in the number of symmetric self-renewing divisions. This phenomenon has been 
observed in single-cell cultures in vitro; thus must be an inherent property of these progenitors (Figure 2A-C) (16). 
 
 Embryonic OPCs migrate long distances whilst continuing to proliferate and eventually populate the whole CNS, 
although this process is not homogeneous. For example, in the spinal cord OPCs of ventral origin are more mobile than those of 
dorsal origin (13, 17). As gestation progresses the length of the cell cycle of OPCs gradually increases from 6h at E13, to 15h at 
E15 only to reach 22h at E17(18). This, in combination with the initiation of differentiation and the increase in levels of apoptotic 
cell death, leads to a plateau in the number of OPCs within the early postnatal CNS, as revealed by pulses of BrdU labeling (18). 
Two main hypotheses were proposed in order to explain the mechanism by which this deceleration of the cell cycle is controlled: 
i) that it is an inherent property of OPCs, in concert with results that revealed that the switch from neurogenesis to 
oligodendrogenesis is maintained in single-cell cultures (19), or ii) that it is controlled through the concerted effects of mitogenic 
and anti-mitogenic extracellular stimuli. In order to address this question transgenic mouse in which expression of platelet-
derived growth factor (PDGF) was either decreased or increased were investigated. PDGF acts on OPCs via activation of 
PDGFRα signaling and enhances their migration, proliferation and survival (20-22). In mice deficient for PDGF the population of 
OPCs was found to be significantly reduced, leading to severe hypomyelination (18, 23). In contrast, over-expression of PDGF 
resulted in increased numbers of OPCs in the spinal cord, caused by a shortening of the cell cycle during early developmental 
stages (E13-E15). Notably though, at E17 cell cycle duration of OPCs was similar when comparing transgenic and wild-type 
animals (18). These results strongly suggest that cell cycle length in OPCs is regulated by mitogens and that its deceleration is 
caused by the limited access to PDGF, although other factors (increased levels of anti-mitotic molecules and inherent properties) 
must also participate in the regulation. Interestingly, the overpopulation of the spinal cord with OPCs did not translate into excess 
numbers of OLs due to increased levels of apoptosis in premyelinating OLs. Therefore, although cell cycle exit is directly 
coupled with initiation of differentiation in embryonic and perinatal OPCs, an increase in the proliferative capacity of the overall 
OPC pool in the normal brain is not linearly linked with increased myelination activity. In contrast, in cases of perinatal hypoxia 
(for example in premature births), in which large-scale apoptosis occurs in OPCs leading to delayed expansion of their population 
and to hypomyelination (24, 25), the induction of proliferation in OPCs can restore the pathology (24). 
 
 Many other growth factors, morphogens and intracellular pathways have been identified to control proliferation of 
OPCs and this is normally coupled with inhibition of differentiation (26) (Table 1). Notably, the same growth molecule can 
induce proliferation of OPCs in one developmental stage and stimulate differentiation in another, with PDGF and neuregulin 
being two such examples (18, 27). In the case of neuregulin, this switch is promoted by the regulated alteration in the expression 
of integrins in OPCs and is manifested as a change in the neuregulin-induced intracellular signaling cascade from the 
phosphatidylinositol-3-OH kinase (PI(3)K) pathway to that of the mitogen-activated kinase (MAPK)(27). Nevertheless, in Erk2-
/- conditional mice (ERK2 is a prototypic member of the MAPK family), in which ERK2 was knocked out specifically in neural 
progenitors, no defect in OPC proliferation was observed (28). The emergence of OPCs from their ancestral neural progenitors is 
largely dependent on fibroblast growth factor (FGF) signaling (29), a factor that controls their proliferation also in later stages 
(30). Similarly, insulin-like growth factor-I (IGF-I) is important both in the initial specification/ expansion stages of OPC 
development and during their main proliferative phase (31, 32). Another intriguing process that controls OPC proliferation is 
neuron-derived signaling. Although this appears to be a major regulating factor, since myelination involves the coupling of OPCs 
and neurons, not much is still known after the seminal work of Barres and Raff (33)(and see Table 1). In a recent study, in vivo 
optogenetic stimulation of deep layer cortical neurons resulted in significant local increases in OPC proliferation, as well as to 
increased differentiation (34). Therefore, although this suggests the existence of a direct link between electrical activity and OPC 
division and complements earlier reports of synaptic activity on OPCs (35), it is still impossible to rule out a primary effect on 
differentiation subsequently leading to the proliferation of OPCs in order to maintain their numbers (43). Nevertheless, the 
significance of the neuron-OPC communication in the control of OPC proliferation seems to be an evolutionary conserved 
mechanism that in Drosophila is mediated by the DNA-binding protein Prospero that is important in the control of asymmetric 





OPEN QUESTIONS: The expression of molecules such as NG2 (37) and integrins (27) has been shown to be important in the 
regulation of OPC proliferation. What other molecules with auto- and para-crine function are expressed in OPCs? Are they 
necessary only for the fine tuning of OPC mitotic behavior? 
 
3.2. Adult brain homeostasis and pathology 
 
After the completion of myelination at the early postnatal period (only in few areas -such as the corpus callosum- 
myelination continues in adulthood in rodents) (38) a fraction of perinatal OPCs retain their progenitor properties and survive in 
the brain parenchyma as adult OPCs (39-41). Recent work using BrdU or EdU pulse-chasing protocols has revealed that all adult 
OPCs remain mitotic with cell cycle lengths significantly longer than those of perinatal OPCs (3, 42). Furthermore, both the 
length of the cell cycle and the mode of division (whether eventually resulting in new OPCs or in OLs) are area-dependent. In 
juvenile mice the cell cycle varies from ≈3 days in the corpus callosum to ≈20 days in the cortex and it slows down further with 
ageing reaching ≈10 days in the corpus callosum and ≈35 days in the cortex (3, 43). Hence, OPCs are considered to be a 
relatively quiescent progenitor population in rodents (44) and the same seems to apply for the human brain, in which almost all 
cycling cells are OPCs proceeding through a long G1 phase (45). Recent experimental work in which cortical OPCs were imaged 
in situ revealed that they remain in a dynamic and motile state, constantly extending and withdrawing processes that allow them 
to sense their microenvironment (46). The disappearance of one OPC either due to cell death or due to differentiation induces a 
neighboring cortical OPC to undergo cell division in order to maintain cell density. These cell mitoses are only rarely directly 
coupled with the initiation of differentiation as the majority of them leads to two OPCs that can differentiate within a range of 
time scales (4, 43, 46, 47). In that way the pool of OPC remains capable to react in future challenges, although it still remains 
elusive if injury or myelination-derived stimuli might also affect directly the proliferative behavior of OPC. The existence of 
wide differentiation time-frames for adult OPCs observed by Hughes et al. (43) is in concert with the conclusions of another 
recent report (48) in which the distribution of myelin in different layers of cortical pyramidal neurons was meticulously explored 
and that revealed that although OPCs are in similar abundance throughout all layers significant differences in the levels of myelin 
are maintained. Notably, morphological studies of proliferating OPCs in adult brain slices and in vivo on one side confirmed the 
existence of symmetric divisions of adult OPCs and showed that these cell retain their structural and even electrophysiological 
properties during the cell cycle (49) and on the other side revealed a significant proportion of divisions with very early signs of 
asymmetry between sister cells (50).  
In contrast, in white matter tracts, such as the corpus callosum, the cell generation pattern seems to be substantially 
different, as within a 65-day chase experiment the majority of OPCs were found to generate myelinating oligodendrocytes and 
not to self-renew (4, 47). These area-specific differences in the mitotic behavior of adult OPCs could again be intrinsic or 
extrinsic and the investigation of this question is still pending, one reason being the lack of protocols allowing the isolation of 
sufficient numbers of adult OPCs. Recent experimental work revealed that areas such as the corpus callosum retain a higher level 
of plasticity in teenagers with myelination patterns being altered in response to external stimuli such as learning or abuse (51-53). 
However, it is far from clear whether this plasticity depends on the proliferative capacity of OPCs, or on changes in rates of 
differentiation and of OL survival. The performance of heterotopic transplantation experiments, in which grey and white matter 
OPCs were grafted into white and grey matter, respectively, confirmed the existence of intrinsic properties that underline the 
higher capacity of white matter OPCs to generate myelin; albeit, this capacity was not linked to significant differences in their 
proliferation or survival abilities (54). In the rodent brain, specific areas of the corpus callosum have also been shown to be 
populated by OPCs of a totally different origin. Those generated by oligodendrogenic adult Neural Stem Cells (NSCs) that are 
located in the stem cell niche found within the Subependymal Zone (SEZ) of the lateral walls of the lateral ventricles (55). When 
isolated and cultured in vitro, these SEZ-derived OPCs exhibit a very active proliferative behaviour, with cell cycle duration 
much shorter that those described for the parenchymal OPCs in vivo. Similarly to embryonic OPCs, growth factors such as IGF-I 
and EGF enhance mitotic activity of adult OPCs (56), whilst exercise was shown to result in further slow-down of their cell cycle 
in contrast to its effects in adult neurogenic progenitors (43). An interesting, but still largely unexplored, mechanism of control of 
OPC behavior seems to be the release of neurotransmitters (mainly of glutamate) from neurons. OPCs have been found to express 
NMDA receptors but it still remains to be elucidated whether and how glutamate signaling affects proliferation or differentiation 
(57, 58). 
 
 Although the mammalian CNS is often referred to as a non-plastic tissue with minimal capacity for regeneration, 
experimental and clinical work over the last decades has clearly shown that this does not apply to the myelin component. Both in 
cases of acute demyelination, such as after traumatic brain injury, but also in chronic demyelinating diseases, such as multiple 
sclerosis, there is strong evidence that substantial or even full repair of myelin (remyelination) occurs (59-62). In experimental 
models of focal demyelination (induced by cortical injury or the intra-CNS administration of toxins such as lysolecithin and 
ethidium bromide that damage OLs and OPCs) it has been shown that OPCs local to the lesion exit quiescence by reducing the 
G1 phase time-length (43) and become highly mitotic, often reaching cell densities higher than normal (63-65). Mitotic activation 
of OPCs is also observed in the periphery of the lesion (63, 66) and experiments in which OPCs are depleted locally using X-ray 
radiation have shown the repopulation of the lesioned areas by OPCs recruited from non-depleted areas (67, 68). Similar mitotic 




Encephalomyelitis) (69). Defects in the control of proliferation or of the mode of division (a bias towards symmetric expansive 
divisions, Figure 2D) (70) in adult OPCs have been suggested to result in the formation of human low-grade and aggressive 
gliomas(71-73) and in highly invasive rodent gliomas (74). Importantly, inhibition of the EGFR signaling pathway prevented 
OPC-driven, but not adult neural stem cell-driven, tumorigenesis suggesting new possible therapeutic strategies (72).  
 
 The ensheathing of neurons by specialized glial cells is important for their function, as suggested by the fact that this 
type of cell-cell interaction has emerged at least three times –independently- during evolution (75) and myelination of nerve 
fibers is considered to be a key factor in the evolution of mammalian and primate cognitive abilities (76, 77). As a consequence it 
has been hypothesized that the cognitive decline observed during ageing and especially in the context of pathologies such as late-
onset alzheimer’s disease might be caused by a failure to maintain myelin homeostasis (77-79). To what extend this involves 
defects in the mitotic capacity of OPCs thatcould lead to the occurrence of OPC-poor areas in the brain remains contradictory. 
According to a recent study, a fraction of OPCs enters senescence in the ageing brain (6) and decreased proliferation of OPCs in 
response to demyelination has been observed in the aged mouse brain (80). On the other hand the self-renewing potential of 
OPCs is not exhausted upon serial demyelinating insults (81), and even high losses of OPCs can be efficiently compensated by 
massive migration of progenitors from unaffected areas (82). Rather than caused by a defect in proliferation of OPCs, 
perturbations in their differentiation capacity are more likely responsible for the age-related decline in remyelination(47, 81, 83, 
84). Importantly, the mitotic capacity of OPCs in the aged rodent brain can be rejuvenated upon exposure to young milieu, as has 




1.What defines when and how many perinatal OPCs will switch to the adult OPC fate (with slower cell cycle, different mode of 
division)? 
2. Is the proliferative behavior of OPCs a major cause for the failure of remyelination in diseases such as multiple sclerosis? 
3. Is OPC exhaustion a major cause for cognitive decline in the ageing brain and in degenerative diseases? 
4. Do adult OPCs retain an element of plasticity as to their mitotic behavior that might underlinethe plasticityin myelination 
observed during learning? 
 
4. MECHANISMS OF CONTROL OF MITOSIS IN OPCS 
 
 In mammals progression through G1 and entry into S phase of the cell cycle is mainly controlled by three different 
protein families and their activity. The key process involves the sequential phosphorylation of the Retinoblastoma protein (Rb) by 
two cyclin/ cyclin-dependent kinase (CDK) complexes. In the middle of the G1 phase cyclinDs can form a protein complex with 
CDK4/6 that phosphorylates Rb which is then targeted for additional phosphorylation by the cyclinE-CDK2 complex. The 
phosphorylated RB inhibits the sequestration of E2F transcription factors and leads to the expression of S phase specific genes 
that promote the G1/S transition. On the other side this transition can be blocked by the activity of cell cycle inhibitory proteins –
the most important belonging to theINK4 and the Kip/Cip families- that often function as tumor suppressors. In OPCs FGF-2 and 
IFG-I dependent stimulation of proliferation is mediated through different intracellular pathways (GSK3β and ERK1/2) that 
converge in the activity of cyclin D1 (85, 86) and neurotransmitters have also been shown to affect directly cell cycle inhibitors 
(87, 88). 
 
 Regarding OPCs, based on single progenitor cultures Temple and Raff proposed the intrinsic clock hypothesis, 
according to which each OPC can divide 8 times before initiating differentiation (89). This was subsequently refined as it was 
revealed that the clock was measuring time rather than number of divisions (90) with PDGF being essential for its operation (21). 
Notably though, the degree to which the operation of such a clock mechanism controls the behavior of OPCs in vivo remains 
controversial. From one hand there is evidence for a close association between OPC birth-date and the timing of their 
differentiation. Dorsally-derived OPCs in the spinal cord are born later than their ventrally-derived counterparts and they start 
generating oligodendrocytes with a similar delay and irrespective of whether ventral OPCs (and the oligodendrocytes they 
generate) are genetically ablated (91, 92). On the other hand we now know that adult OPCs remain ubiquitously in the cell cycle 
(3, 93), that they proliferate in response to demyelination, that their numbers are not exhausted even after repeated degenerative 
insults (81) and that they can be rejuvenated (80). A central hypothesis formed to explain how the clock model works was that 
cell cycle inhibitory factors gradually accumulate, leading -once over a threshold- into mitosis inhibition. However, long-term 
culture experiments of perinatal OPCs revealed that the accumulation p21cip/kip, p27cip/kip and p57cip/kipcyclin kinase inhibitors and 
of p53 was counterbalanced by gradual increases in the expression of CDKs 2, 4 and of cyclins D1, D3 and E (93). Indeed, the 
operation of such compensatory mechanisms, either at a cellular or molecular level, safeguards normal developmental and 
myelination programs. Mice deficient for p27cip/Kip did not show a major defect in myelination and were only characterized by an 
increased number of progenitor cells that still differentiated appropriately in vivo (94). Furthermore, in cdk2knockout mice 
myelination was completely unaffected, possibly due to over expression of CDK4 (24). Notably, expression of CDK4 is 
downregulated after postnatal day 15 in the mouse brain and proliferation of adult OPCs in response to demyelination is 
decreased incdk2-/- mice (95). In the adult rodent brain OPCs are also generated from neural stem cells located within the 
subependymal zone (SEZ) cytogenic niche (96-99) and the proliferation of SEZ-derived OPCs is also impaired in cdk2-/- mice 




the absence of compensatory mechanisms. Embryonic/ perinatal fast-cycling and adult slowly-cycling OPCs also differ to their 
dependency on cyclinD1, with only the adult ones being significantly affected in cdkD1-/- mice (100, 101). As discussed above, 
during development it is necessary to couple the exit of OPCs from the cell cycle with the initiation of differentiation and the 
engagement with neuronal axons in order to generate myelinating OLs at the correct place and time. This requires the operation 
of multiple layers of fine regulation and the study of several knockout mice, in which expression of various transcription factors 
(such as Olig2, Nkx2.2., Sox5 and 6, Id2 and 4) is perturbed, has shown that the usual effect is not a total block of self-renewal or 
a total block of exit from the cell cycle (indicating exhaustion or expansion of OPCs), as a clock mechanism would dictate, but 
rather defects in the fine tuning resulting in delayed or incomplete formation of myelin (102-106). This coupling apparently 
become less important during adult brain homeostasis, when differentiation is not tightly linked to cell cycle exit, and this might 
be why there are fewer compensatory mechanisms in adult OPCs (rendering them more vulnerable to cdk2 knocking out) and 
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Factor Effect on OPC proliferation and / or differentiation Reference 
PDGF Enhances and is necessary for OPC proliferation in vitro and in vivo. Blocks cell cycle exit and preservees OPCs in an 
immature progenitor state. 
(18, 20, 23, 93, 
107) 
FGF-2 increases the expression of PDGFR-A, thereby indirectly enhancing sensitivity to PDGF signalling (30, 108, 109) 
IGF-1 increases proliferation of OPCs in vitro through  regulation of G2/M progression in vitro (31, 32, 56, 85, 
86, 110) 




CNTF Can act synergistically with PDGF-AA. Increases survival of OPCs in vitro. (111) 
BDNF enhances OPC proliferation in vitro synergistically with NT-3, increased OPC proliferation in a spinal cord contusion 
model in rats 
(112) 
NT-3 enhances OPC proliferation in vitro, acts synergistically with PDGF-AA, block of NT-3 signalling with anti-NT-3 
antibodies reduced the number of proliferating OPCs in the optic nerve during development in rats, promotes proliferation 
of OPCs in a contused spinal cord model in adult rats 
(111-113) 
 
Il-6 enhances OPC survival  (111) 
LIF  enhances OPC survival (111, 114) 
GGF2/ neuregulin enhances OPC proliferation in vitro. Enhances OPC proliferation in EAE models (115, 116) 
TGF-beta Promotes OPC differentiation, ihibits progenitor proliferation  (117) 
cAMP Promotes OPC differentiation (88, 118-120) 
Wnt3/3a Promotes specifically the proliferation of oligodendrogneic adult NSCs  
beta-adrenergic 
receptor agonists 
Promotes OPC cell cycle exit in G1 and blocks S phase entry in vitro (87) 
Glutamate Promotes OPC cell cycle exit in vitro and in cerebellar slice cultures (87) 
Thyroid hormones 
(T3 and T4)  
Important for OPC differentiation in vitro and in vivo, promotes cell cycle exit and blocks OPC proliferation in vitro (121-124) 
Electrical activity enhances OPC proliferation in vivo (33, 34) 
M1 polarised 
macrophages 
conditioned medium from M1 polarised macrophages enhanced proliferation of OPCs in vitro (125) 
M2 polarised 
macrophages 
conditioned medium from M2 polarised macrophages enhanced proliferation and differentiation of OPCs in vitro  (125) 
BDNF: Brain-Derived Neurotrophic Factor; cAMP: cyclic Adenosine MonoPhosphate; CNTF: CiliaryNeuroTrophic Factor; 
FGF-2: Fibroblast Growth Factor 2; GGF2: GliaGrowth Factor 2; IGF-1: Insulin-like Growth Factor 1; Il-6: Interleukin-6; LIF: 
Leukemia Inhibitory Factor; NT-3: Neurotrophin-3; PDGF: Platelet-Derived Growth Fcator; TGF-beta: Transforming Growth 
Factor beta 
 




























Figure 1. OPCs and Oligodendrocytes in vitro and in vivo.(A) Microphotograph of OPCs isolated from adult rat brain and kept 
in growth medium after immunostaining for the proteoglycan NG2 (in red) that is a characteristic marker of OPCs and for the key 
oligodendroglial lineage transcription factor Olig2 (in green). Arrowheads point to the characteristic bipolar morphology of an 
OPC in culture. (B) Microphotograph of a premyelinatingoligodendrocyte, as identified by the expression of Myelin Based 
Protein (in red). The arrow indicates one process that is in contact with a neuronal axon (axons are marked by neurofilament 
staining, in blue). Expression of EYFP (in green, both in B and C) indicates that this cell is derived from adult neural stem cells 
located in the subependymal zone stem cell niche (OPCs generated by stem cells isolated from hGFAP-CreERT2 x Rosa26-EYFP 
mice were co-cultured with dorsal root ganglion cells). (C) Microphotograph of a myelinatingoligodendrocyte, as identified by 
the expression of Myelin Based Protein (in red) and the formation of characteristic myelin sheaths surrounding neuronal axons 
(characteristic examples are indicated by arrows, axons are marked by neurofilament staining, in blue). (D) Microphotograph of 
chains of oligodendrocytes, as identified by expression of both Olig2 (in white) and CC1 (a marker of mature oligodendrocytes, 
in red). An astrocyte (marked by expression of GFAP, in green) is intercalated, whilst the two cells indicated by the yellow 










































Figure 2. Patterns of proliferation and differentiation of single neural progenitors and OPCs. (A) Proliferation and differentiation 
tree of a clone generated in vitro by a single embryonic cortical neural progenitor. Note that all differentiated cells that were 
generated were neurons. (B)Proliferation and differentiation tree of a clone generated in vitro by a single embryonic cortical 
neural progenitor that gave rise exclusively to oligodenrocytes. (C) Proliferation and differentiation tree of a clone generated in 
vitro by a single embryonic cortical neural progenitor that gave rise in both neurons (marked by “N”) and oligodendrocytes 
(marked by “-“). Note that the generation of oligos coincided with additional symmetrical divisions of the progenitors. (D) 
Proliferation and differentiation tree of clones generated in vivo by single adult cortical OPCs using time lapse imaging. Note that 
the main pattern within the 40-day chase period was that of proliferation without differentiation events. (E) Proliferation and 
differentiation tree of clones generated in vitro by single adult NSCs isolated from the SEZ using time lapse imaging. Note that -
bearing in mind the in vitro/ in vivo differences- NSC-derived cells seem to have significantly shorter cell cycle. ((A,C) 
Reproduced with permission from (19); (B) reproduced with permission from (16)) 
 
